Health ยท GS2
Prescription safeguard for cough syrups
One line
The Health Ministry amended the Drugs Rules, 1945, withdrawing an exemption that had allowed certain cough-syrup sales in small villages without the usual prescription safeguard.
Summary
Medicine access must be balanced with safe use. Cough and cold combinations may be unsuitable for some children or conditions, while weak retail oversight can encourage irrational use.
PYQ pattern
UPSC may link drug regulation with access, patient safety, federal enforcement, and public-health capacity.
Core notes
- Prescription requirements help ensure clinical assessment for specified medicines.
- Rural access also depends on qualified providers, pharmacies, and affordable alternatives.
- Labels, formulation, dosage, and age restrictions matter in paediatric medicine safety.
- Regulation must be paired with enforcement and public communication.
Prelims lens
- The Drugs Rules, 1945 operate under India's drugs-and-cosmetics legal framework.
- A retail exemption is different from approval of a medicine's safety or efficacy.
- Fixed-dose combinations contain two or more active ingredients in a fixed ratio.
MCQ 1
Withdrawing a retail exemption means:
- A. The usual regulatory condition again applies
- B. Every cough medicine is banned
- C. No prescription medicine can be sold nationally
- D. The Drugs Rules cease to operate
Reveal answerHide answer
A
Removal of an exemption restores the general requirement to the affected sales.
MCQ 2
Which is necessary for safer paediatric medicine use?
- A. Age-appropriate dosage and clear labels
- B. Identical doses for every age
- C. No pharmacovigilance
- D. Unverified promotional claims
Reveal answerHide answer
A
Children require formulation and dosage safeguards appropriate to age and weight.
Mains
Question, 10 marks, 150 words: How can India reconcile rural access to medicines with stronger drug-safety regulation?
Approach:
- Explain the access-safety trade-off.
- Discuss prescriptions, providers, pharmacies, and enforcement.
- Note paediatric and irrational-use risks.
- Suggest telemedicine, generic access, and surveillance.